JPS56108712A - Lecithin cholesterol acyl transferase activator - Google Patents
Lecithin cholesterol acyl transferase activatorInfo
- Publication number
- JPS56108712A JPS56108712A JP1073780A JP1073780A JPS56108712A JP S56108712 A JPS56108712 A JP S56108712A JP 1073780 A JP1073780 A JP 1073780A JP 1073780 A JP1073780 A JP 1073780A JP S56108712 A JPS56108712 A JP S56108712A
- Authority
- JP
- Japan
- Prior art keywords
- lecithin
- pantethine
- activator
- lcat
- acyl transferase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1073780A JPS56108712A (en) | 1980-01-31 | 1980-01-31 | Lecithin cholesterol acyl transferase activator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1073780A JPS56108712A (en) | 1980-01-31 | 1980-01-31 | Lecithin cholesterol acyl transferase activator |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56108712A true JPS56108712A (en) | 1981-08-28 |
JPS6345371B2 JPS6345371B2 (US20100268047A1-20101021-C00003.png) | 1988-09-09 |
Family
ID=11758600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1073780A Granted JPS56108712A (en) | 1980-01-31 | 1980-01-31 | Lecithin cholesterol acyl transferase activator |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56108712A (US20100268047A1-20101021-C00003.png) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995034811A1 (en) * | 1993-06-11 | 1995-12-21 | Oculon Corporation | Protein condensation inhibitors and methods related thereto |
WO2015050148A1 (ja) * | 2013-10-04 | 2015-04-09 | 第一三共株式会社 | 3-アリールピラゾロピリジン誘導体 |
WO2015076353A1 (ja) * | 2013-11-25 | 2015-05-28 | 第一三共株式会社 | 3-アルキルピラゾロピリジン誘導体 |
-
1980
- 1980-01-31 JP JP1073780A patent/JPS56108712A/ja active Granted
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995034811A1 (en) * | 1993-06-11 | 1995-12-21 | Oculon Corporation | Protein condensation inhibitors and methods related thereto |
WO2015050148A1 (ja) * | 2013-10-04 | 2015-04-09 | 第一三共株式会社 | 3-アリールピラゾロピリジン誘導体 |
WO2015076353A1 (ja) * | 2013-11-25 | 2015-05-28 | 第一三共株式会社 | 3-アルキルピラゾロピリジン誘導体 |
Also Published As
Publication number | Publication date |
---|---|
JPS6345371B2 (US20100268047A1-20101021-C00003.png) | 1988-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2047686A1 (en) | Dietary supplement for insulin-resistant diabetics | |
EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
NO951592L (no) | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system | |
AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
DK642587A (da) | Insulinpraeparat | |
ES8201596A1 (es) | Procedimiento de obtencion de mucopolisacaridos | |
PL287844A1 (en) | Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases | |
DE3575076D1 (de) | Katheter fuer rueckinfusion von pharmazeutischen agenten. | |
ATE65696T1 (de) | Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche. | |
ATE65912T1 (de) | Arzneimittelzusammensetzungen ermaessigter toxizitaet. | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
JPS56108712A (en) | Lecithin cholesterol acyl transferase activator | |
FR2362849A1 (fr) | Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant | |
FR2428649A1 (fr) | Diesters en 17,21 de l'hydrocortisone et medicaments qui en contiennent | |
EG17992A (en) | Preparation of a medicament for arthritis and theumatism | |
NO862321D0 (no) | Fysiologisk middel for oekning av transdermal avlevering av legemidler. | |
MY114218A (en) | The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations. | |
KR880010762A (ko) | 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers) | |
ATE55254T1 (de) | Verminderung der toxischen wirkungen von anthrachinon-medikamenten. | |
SU637117A1 (ru) | Способ диагностики туберкулеза | |
Rich et al. | Agranulocytosis resulting from methimazole (tapazole): report of three cases | |
熊宁宁 et al. | EFFECTS OF TCM THERAPY ON THE PROGRESSION OF CHRONIC RENAL FAILURE CAUSED BY PRIMARY GLOMERULONEPHRITIS | |
Cidad | Metabolic effects of beta-blocking drugs. Their association with diuretics in the treatment of arterial hypertension. | |
UA15281A (uk) | Спосіб лікуваhhя хроhічhої ішемічhої хвороби серця |